Medtronic patent award
This article was originally published in The Gray Sheet
AGA Medical must pay Medtronic $57 million in past damages and an 11% royalty on future U.S. sales of its Amplatzer Occluder and vascular plug product lines through 2018, following a San Francisco district court decision that the product lines infringe Medtronic's two "Jervis" patents, the firms said Aug. 6. AGA Medical plans to "vigorously defend" the case, and notes that a non-jury trial scheduled for later this year could alter the final outcome. Medtronic also has sued W.L. Gore, alleging infringement of the same patents
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.